WHO Director General Dr Tedros Adhanom Ghebreyesus joined the chorus of world leaders wishing United States President Donald Trump and his wife a speedy recovery from COVID-19 – while the US presidential campaign entered uncharted waters, with the cancellation of campaign rallies and fears that other White House Staff and political allies who had accompanied […] Continue reading ->
Moderna intends to seek US Food and Drug Administration emergency authorization for its COVID-19 vaccine candidate for frontline medical workers by November 25th at the earliest, and only in late January for use in the general population.  That means that the vaccine, if approved on schedule, would only be available for widespread distribution to the […] Continue reading ->
Political leaders should find a way to collaborate and “follow the science,” taking a page from researchers, public health practitioners, and healthcare workers who have learned to work together during the COVID-19 pandemic, WHO Health Emergencies Executive Director Mike Ryan said on Friday. “The people have found a way to cooperate, leaders need to find […] Continue reading ->
Against the backdrop of Thursday’s G-20 Health and Finance Ministers meeting on the COVID-19 pandemic, UN and Global health leaders were escalating their pleas to the world’s industrialized countries and global financial institutions for billions of dollars in immediate funding to fight the COVID-19 pandemic. The calls echoed statements issued earlier this week by the […] Continue reading ->
The US Biomedical Advanced Research and Development Agency (BARDA) is investigating Moderna’s patents for allegedly failing to disclose federal funding, making it the second US agency to review the company’s patents. The BARDA probe comes just days after the US Defense Advanced Research Projects Agency (DARPA) began an investigation into Moderna’s patents, after pharma watchdog […] Continue reading ->
The United States Defense Advanced Research Projects Agency (DARPA) is investigating Moderna, a company developing a much hyped COVID-19 vaccine candidate, for allegedly failing to disclose federal funding on its US patent applications. A Moderna spokesperson on Monday told Health Policy Watch that “the Company believes it has complied with applicable patent reporting requirements regarding patent filings.” […] Continue reading ->